Blue Mammoth is a modern autoflowering strain developed through the hybridization of Skunk No. 1 and a Russian Ruderalis. The integration of the Ruderalis genetics allows for a condensed life cycle, resulting in a flowering period of 75 days. This strain can be cultivated in both indoor and outdoor environments, and while it is considered easy to manage, growers should anticipate a low yield.

The chemical profile of Blue Mammoth is characterized by a specific sequence of primary and secondary compounds. Its terpene profile identifies terpinolene as the dominant constituent, followed by myrcene, caryophyllene, ocimene, limonene, pinene, humulene, beta-pinene, linalool, nerolidol, alpha-terpinene, and bisabolol. This complex array of terpenes informs the strain’s sensory experience, creating a nuanced aromatic and flavor profile for the end user.

This THC-dominant cultivar is reported to produce effects that are relaxed, happy, and uplifted. Because of these primary psychoactive attributes, the strain is utilized by consumers to address stress, pain, and sleep difficulties. Blue Mammoth has no recorded offspring, serving as a stable, modern autoflowering option for those seeking consistent therapeutic and recreational applications.